Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study is a multicenter RCT to compare 3-year overall survival(OS) rate, progression free survival(PFS),local progression free survival(LPFS),regional progression free survival(RPFS),distant metastasis free survival(DMFS), and toxicities of endonasal endoscopic surgery versus IMRT.
Epistemonikos ID: 57d2b245926d11424806d4c178e897c50346fbf7
First added on: May 06, 2024